LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $69,630 | +54.2% | 30,013 | +87.4% | 0.00% | – |
| Q1 2024 | $45,157 | -11.3% | 16,013 | 0.0% | 0.00% | – |
| Q4 2023 | $50,921 | -22.9% | 16,013 | -20.0% | 0.00% | -100.0% |
| Q3 2023 | $66,043 | +42.8% | 20,013 | +42.8% | 0.00% | – |
| Q2 2023 | $46,243 | -30.2% | 14,013 | -30.0% | 0.00% | -100.0% |
| Q1 2023 | $66,243 | +91904.2% | 20,013 | 0.0% | 0.00% | – |
| Q4 2022 | $72 | -100.0% | 20,013 | +17.6% | 0.00% | -100.0% |
| Q3 2022 | $151,000 | -27.4% | 17,013 | -37.0% | 0.00% | 0.0% |
| Q2 2022 | $208,000 | -20.9% | 27,013 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $263,000 | – | 28,013 | +215384.6% | 0.00% | – |
| Q2 2020 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $14,540,000 | 2.80% |
| Opaleye Management Inc. | 281,287 | $10,045,000 | 1.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $33,435,000 | 0.66% |
| NEA Management Company, LLC | 526,663 | $18,807,000 | 0.50% |
| Investors Financial Group, LLC | 18,200 | $650,000 | 0.43% |
| One68 Global Capital, LLC | 5,855 | $209,000 | 0.42% |
| Wealth Advisors of Iowa, LLC | 11,760 | $420,000 | 0.26% |
| Blackstone Inc. | 468,145 | $16,717,000 | 0.06% |
| Foster Group, Inc. | 7,283 | $221,000 | 0.04% |
| Texas Yale Capital Corp. | 16,000 | $571,000 | 0.04% |